Literature DB >> 21497178

X-linked GnRH deficiency: role of KAL-1 mutations in GnRH deficiency.

Youli Hu1, Pierre-Marc Bouloux.   

Abstract

The gene for X-linked Kallmann's syndrome (KAL-1, encoding anosmin-1) was cloned in 1991. Over a decade elapsed before autosomal forms of KS and most of other genetic forms of isolated hypogonadotrophic hypogonadism (IHH) became characterized, and the genetic diversity of these disorders fully appreciated. Although KAL-1 mutations appear to cause a more severe reproductive phenotype than other IHH genes, the biology of this multidomain extracellular matrix protein has only been partially characterized. Initial studies suggested a central role of anosmin-1, in GnRH neuron ontogeny - specifically in GnRH neuronal migration from the cribriform plate area into the brain - as well as in olfactory bulb development. Anosmin-1 is expressed extracellularly, with high affinity binding to cell membrane heparan sulphate proteoglycans. It is expressed in the outer layers of the developing olfactory bulb, the neuroretina, the cerebellum, spinal cord and developing kidney. Recent observations have demonstrated an anosmin-1 heparan sulphate dependent functional interaction with the product of the autosomal dominant KAL-2 (FGFR1: anosmin-2) gene, thereby modulating FGFR1 signalling. Although these genes are frequently co-expressed in developing tissues, this may not represent the sole mode of action of anosmin-1, and FGFR1 independent actions of the protein have also been identified. Structural and in vitro functional studies have shown that anosmin-1 may have complex biological actions. Anosmin-1 interactions with FGFR1 have however been best characterized and represent the dominant focus of this chapter.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497178     DOI: 10.1016/j.mce.2011.04.001

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

1.  Transforming growth factor-β regulates the expression of anosmin (KAL-1) in human retinal pigment epithelial cells.

Authors:  Raghavan Raju; Bixi Jian; John J Hooks; Chandrasekharam N Nagineni
Journal:  Cytokine       Date:  2013-01-26       Impact factor: 3.861

2.  Invertebrate models of kallmann syndrome: molecular pathogenesis and new disease genes.

Authors:  Elia Di Schiavi; Davide Andrenacci
Journal:  Curr Genomics       Date:  2013-03       Impact factor: 2.236

3.  Novel application of luciferase assay for the in vitro functional assessment of KAL1 variants in three females with septo-optic dysplasia (SOD).

Authors:  Mark J McCabe; Youli Hu; Louise C Gregory; Carles Gaston-Massuet; Kyriaki S Alatzoglou; José W Saldanha; Angelica Gualtieri; Ajay Thankamony; Ieuan Hughes; Sharron Townshend; Juan-Pedro Martinez-Barbera; Pierre-Marc Bouloux; Mehul T Dattani
Journal:  Mol Cell Endocrinol       Date:  2015-09-14       Impact factor: 4.102

4.  ANOS1: a unified nomenclature for Kallmann syndrome 1 gene (KAL1) and anosmin-1.

Authors:  Fernando de Castro; Ruth Seal; Roberto Maggi
Journal:  Brief Funct Genomics       Date:  2017-07-01       Impact factor: 4.241

5.  Whole genome investigation of an atypical autism case identifies a novel ANOS1 mutation with subsequent diagnosis of Kallmann syndrome.

Authors:  Paul A Dawson; Soohyun Lee; Adam D Ewing; Johannes B Prins; Helen S Heussler
Journal:  Mol Genet Metab Rep       Date:  2020-04-29

6.  Anosmin-1 activates vascular endothelial growth factor receptor and its related signaling pathway for olfactory bulb angiogenesis.

Authors:  Shoko Matsushima; Akio Shimizu; Manami Kondo; Hirotsugu Asano; Nobuhiro Ueno; Hironao Nakayama; Naoko Sato; Masahiro Komeno; Hisakazu Ogita; Misuzu Kurokawa-Seo
Journal:  Sci Rep       Date:  2020-01-13       Impact factor: 4.379

7.  The Clinical and Genetic Characteristics in Children with Idiopathic Hypogonadotropin Hypogonadism.

Authors:  Qiong Zhou; Wenbin Sheng; Suhong Yang; Chaochun Zou
Journal:  J Oncol       Date:  2022-09-19       Impact factor: 4.501

8.  Exogenous kisspeptin administration as a probe of GnRH neuronal function in patients with idiopathic hypogonadotropic hypogonadism.

Authors:  Yee-Ming Chan; Margaret F Lippincott; James P Butler; Valerie F Sidhoum; Cindy X Li; Lacey Plummer; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.